News
“Generating HiFi reads directly on the Sequel IIe System now has the potential to further accelerate cost-effective access to this information-rich sequencing data.” PacBio HiFi reads combine ...
PacBio’s projected sales growth of 8.4% is favorable to the industry’s 5.9%. Zacks Investment Research Image Source ... of the company’s Sequel IIe system in the study of genetic disease.
sequencing capacity by adding two new PacBio Sequel IIe Systems. Radboudumc has been utilizing PacBio long-read technology to detect hidden variants causing rare diseases over the past three years.
PacBio’s Sequel IIe Selected by Prenetics to Build Personalized Genomics for Healthcare Leading global genomics and diagnostic testing firm adds more comprehensive genetic information to its ...
Pacific Biosciences of California, Inc. PACB recently introduced the Sequel IIe System, the next instrument evolution powered by its Single Molecule, Real-Time (SMRT) Sequencing technology.This ...
Oct. 05, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced the ...
sequencing capacity by adding two new PacBio Sequel IIe Systems. Radboudumc has been utilizing PacBio long-read technology to detect hidden variants causing rare diseases over the past three years.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results